Global Information
회사소개 | 문의

협심증 : 주요 20개국 시장 예측

Epiomic Epidemiology Series: Angina Pectoris Forecast in 20 Major Markets 2018-2028

리서치사 Black Swan Analysis
발행일 2018년 08월 상품 코드 339841
페이지 정보 영문 68 Pages
가격
US $ 5,800 ₩ 6,658,400 PDF by E-mail (Single User License)
US $ 8,700 ₩ 9,987,600 PDF by E-mail (Site License)
US $ 10,400 ₩ 11,939,200 PDF by E-mail (Global License)


협심증 : 주요 20개국 시장 예측 Epiomic Epidemiology Series: Angina Pectoris Forecast in 20 Major Markets 2018-2028
발행일: 2018년 08월 페이지 정보 : 영문 68 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

협심증은 심근이 산소가 풍부하게 포함된 혈액을 충분히 공급할 수 없을 때에 통증이나 불쾌감을 느끼게 됩니다. 협심증의 주요인은 관상동맥질환(CAD)을 들 수 있습니다.

주요 20개국 시장(미국, 캐나다, 프랑스, 독일, 이탈리아, 스페인, 영국, 폴란드, 네덜란드, 아일랜드, 러시아, 터키, 일본, 중국, 한국, 인도, 호주, 브라질, 멕시코, 아르헨티나)의 협심증(Angina Pectoris) 현재 환자수(성별, 연령 코호트별)에 대해 조사 분석했으며, 현재 유병률, 질환 개요, 위험인자, 질환의 진단과 예후, 주요 증상과 합병증 등의 정보를 정리하여 전해드립니다.

도표

서론

병인

위험인자와 예방

질환의 진단

변이 : 지역/민족별

질환의 예후와 임상 경과

질환에 관련된 주요 합병증/특징

환자수 정량화 방법

협심증 최대 환자수

협심증 환자의 특징

  • 관상동맥 질환이 있는 협심증 환자

약어

기타 서비스 및 솔루션

  • 보고서 및 출판물
  • 온라인 역학 데이터베이스
  • 온라인 약가 데이터베이스

참고 문헌

부록

LSH 18.08.01

영문목차

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Angina Pectoris in 20 Major Markets

Angina Pectoris (AP) is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which is the obstruction of coronary arteries due to build up of atherosclerotic plaque. Other forms of angina include microvascular angina (MVD) also known as Cardiac Syndrome X.

This report provides the current prevalent population for AP across 20 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of course of progression, coronary vessels affected and associated co-morbidities of AP. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, patient parameters and co-morbidities of AP have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AP include:

Diabetes

Hypertension

Dyslipidaemia

Chronic heart failure

Peripheral artery disease

Erectile dysfunction

Aortic valve sclerosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

Ability to quantify patient populations in global AP market to target the development of future products, pricing strategies and launch plans.

Further insight into the prevalence of the subdivided types of AP and identification of patient segments with high potential.

Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

Better understanding on the impact of specific co-morbid conditions on the prevalent population of AP patients.

Identification of AP patient sub-populations that require treatment.

Better understanding of the specific markets that have the largest number of AP patients.

CONTENTS

  • LIST OF TABLES AND FIGURES
  • INTRODUCTION
  • CAUSE OF THE DISEASE
  • RISK FACTORS & PREVENTION
  • DIAGNOSIS OF THE DISEASE
  • VARIATION BY GEOGRAPHY/ETHNICITY
  • DISEASE PROGNOSIS & CLINICAL COURSE
  • KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
  • METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
  • TOP-LINE PREVALENCE FOR ANGINA PECTORIS
  • FEATURES OF ANGINA PECTORIS PATIENTS
  • ANGINA PECTORIS PATIENTS WITH CORONARY ARTERY DISEASE
  • ABBREVIATIONS USED IN THE REPORT
  • OTHER BLACK SWAN SERVICES & SOLUTIONS
  • REPORTS & PUBLICATIONS
  • ONLINE EPIDEMIOLOGY DATABASES
  • ONLINE PHARMACEUTICAL PRICING DATABASE
  • REFERENCES
  • APPENDIX

LIST OF TABLES AND FIGURES

  • Table 1. Canadian Cardiovascular Society (CCS) classification scale of angina pectoris
  • Table 2. Prevalence of angina pectoris, total (000s)
  • Table 3. Prevalence of angina pectoris, males (000s)
  • Table 4. Prevalence of angina pectoris, females (000s)
  • Table 5. Patients with angina pectoris by severity (CCS), total (000s)
  • Table 6. Patients with angina pectoris by BMI status, total (000s)
  • Table 7. Angina pectoris patients with coronary artery disease by type, total (000s)
  • Table 8. Patients with angina pectoris by CAC score, total (000s)
  • Table 9. Abbreviations and acronyms used in the report
  • Table 10. USA prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 11. USA prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 12. Canada prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 13. Canada prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 14. France prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 15. France prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 16. Germany prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 17. Germany prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 18. Italy prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 19. Italy prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 20. Spain prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 21. Spain prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 22. UK prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 23. UK prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 24. Poland prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 25. Poland prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 26. Netherlands prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 27. Netherlands prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 28. Ireland prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 29. Ireland prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 30. Russia prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 31. Russia prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 32. Turkey prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 33. Turkey prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 34. Japan prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 35. Japan prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 36. China prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 37. China prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 38. South Korea prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 39. South Korea prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 40. India prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 41. India prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 42. Australia prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 43. Australia prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 44. Brazil prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 45. Brazil prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 46. Mexico prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 47. Mexico prevalence of angina pectoris by 5-yr age cohort, females (000s)
  • Table 48. Argentina prevalence of angina pectoris by 5-yr age cohort, males (000s)
  • Table 49. Argentina prevalence of angina pectoris by 5-yr age cohort, females (000s)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research